Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PRVA · against 1,336 other Healthcare companies
Ranked #770 of 1,337 · scores higher than 42% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 40–49, including PRVA · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | PRVA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 1.0% | 1.5% | 46% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 2.4% | 4.2% | 40% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 4.8% | -1.0% | 78% | 20% | |
| Book yieldHigher is better · 1,306 reported | 28.9% | 37.9% | 39% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 770 | 1.1B NOK (≈$105M) | 42 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 58 |
| 770 | 5.1B USD | 42 | 52 |
| 770 | 1.1B USD | 42 | 31 |
| 770 | 915M USD | 42 | 57 |
| 770 | 2.7B USD | 42 | 56 |
| 770 | 5.8B USD | 42 | 38 |
| 770 | 303.5B INR (≈$3.6B) | 42 | 47 |
| 783 | 64.1B CNY (≈$9.0B) | 41 | 48 |
| 783 | 6.3B CNY (≈$877M) | 41 | 52 |